Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Hamby, M. Pallansch, O. Kew (1987)
Reemergence of an epidemic coxsackievirus B5 genotype.The Journal of infectious diseases, 156 2
A. Henke, E. Wagner, J. Whitton, R. Zell, A. Stelzner (1998)
Protection of Mice against Lethal Coxsackievirus B3 Infection by Using DNA ImmunizationJournal of Virology, 72
I. Leneva, I. Fediakina, T. Gus’kova, R. Glushkov (2005)
[Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A].Terapevticheskii arkhiv, 77 8
(1999)
Arbidol: a new antiviral, immunomodulator and interferon-inducer
M. Brooks, J. Sasadeusz, G. Tannock (2004)
Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what’s in the pipeline?Current Opinion in Pulmonary Medicine, 10
Luis Carrasco (1994)
Picornavirus inhibitorsPharmacology & Therapeutics, 64
H. Chai, Yanfang Zhao, Chunshen Zhao, P. Gong (2006)
Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 6-bromo-5-hydroxy-1H-indole-3-carboxylates.Bioorganic & medicinal chemistry, 14 4
A. Henke, R. Zell, A. Stelzner (2001)
DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice.Antiviral research, 49 1
Hirobumi Yamamoto, Katsuhiko Yoshida, Y. Kondo, Kenichiro Inoue (1998)
Production of cornoside in Abeliophyllum distichum cell suspension culturesPhytochemistry, 48
A. Reed (1938)
A left superior vena cava draining the blood from a closed coronary sinus.Journal of anatomy, 73 Pt 1
Y. Boriskin, I. Leneva, E. Pécheur, S. Polyak (2008)
Arbidol: a broad-spectrum antiviral compound that blocks viral fusion.Current medicinal chemistry, 15 10
D. Galbraith, Carron Nairn, Geoffrey Clements (1997)
Evidence for enteroviral persistence in humans.The Journal of general virology, 78 ( Pt 2)
J. White, J. Kartenbeck, A. Helenius (1982)
Membrane fusion activity of influenza virus.The EMBO Journal, 1
J. Fohlman, K. Pauksen, B. Morein, U. Bjare, N. Ilbäck, G. Friman (1993)
High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis.Scandinavian journal of infectious diseases. Supplementum, 88
Rebecca Rich, M. McErlean (1993)
Complete heart block in a child with varicella.The American journal of emergency medicine, 11 6
J. Lenzo, G. Shellam, C. Lawson (2001)
Ganciclovir and Cidofovir Treatment of Cytomegalovirus-Induced Myocarditis in MiceAntimicrobial Agents and Chemotherapy, 45
(1999)
ArbidolDrugs R D, 2
(1999)
Arbidol kinetics and its effect on influenza A virus replication in MDCK cell culture
Yao-lan Li, P. But, V. Ooi (2005)
Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin.Antiviral research, 68 1
Canan Baykurt, K. Çağlar, N. Ceviz, C. Akyuz, G. Seçmeer (1999)
Successful treatment of Epstein–Barr virus infection associated with myocarditisPediatrics International, 41
Li-qiao Shi, H. Xiong, Jing He, H. Deng, Q. Li, Qiong Zhong, Wei Hou, L. Cheng, H. Xiao, Zhan-Qiu Yang (2007)
Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivoArchives of Virology, 152
A. Ramsingh, N. Chapman, S. Tracy (1997)
Coxsackieviruses and diabetesBioEssays, 19
A. Garozzo, C. Cutrì, A. Castro, Gianna Tempera, F. Guerrera, M. Sarvà, E. Geremia (2000)
Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives.Antiviral research, 45 3
Y. Boriskin, E. Pécheur, S. Polyak (2006)
Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infectionVirology Journal, 3
I. Leneva, M. Sokolova, I. Fediakina, M. Khristova, N. Fadeeva, T. Gus’kova (2002)
[Study of the effect of antiviral drugs on the reproduction of the respiratory syncytial virus by enzyme immunoassay].Voprosy virusologii, 47 2
J. Schulman (1968)
Effect of 1-Amantanamine Hydrochloride (Amantadine HCl) and Methyl-1-Adamatanethylamine Hydrochloride (Rimantadine HCl) on Transmission of Influenza Virus Infection in MiceProceedings of the Society for Experimental Biology and Medicine, 128
H. Rotbart (2002)
Treatment of picornavirus infections.Antiviral research, 53 2
P. Muir, F. Nicholson, S. Illavia, T. McNeil, J. Ajetunmobi, H. Dunn, W. Starkey, K. Reetoo, N. Cary, J. Parameshwar, Jangu Banatvala (1996)
Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy.Heart, 76
We investigated the antiviral activity of Arbidol, an antiviral chemical compound, against Coxsackie virus B5 (CVB 5 ) in vitro and in vivo. Arbidol not only prevented the cytopathic effect (CPE) of CVB 5 , as demonstrated in an MTT colorimetric assay, when added during or after viral infection, with a 50% inhibitory concentration (IC 50 ) from 2.66 to 6.62 μg/ml, but it also decreased the CVB 5 -RNA level in infected host cells, as shown in semi-quantitative RT-PCR. BALB/c mice were used as an animal model to test the Arbidol activity in vivo. Orally administered Arbidol at 50 mg/kg body weight/day (once a day) significantly reduced mean virus yields in the lungs and heart as well as mortality after infection for 6 days. Our results demonstrate that in vitro and in vivo infection with CVB 5 can be effectively treated by Arbidol.
Archives of Virology – Springer Journals
Published: Apr 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.